ArticleInternational journal of hygiene and environmental health2026
Per- and polyfluoroalkyl substances serum concentrations during pregnancy and gestational weight gain in the Healthy Start Study.
Article in International journal of hygiene and environmental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPer- and polyfluoroalkyl substances (PFAS) are widespread and persistent contaminants detected in most humans. PFAS exposure has been linked to adverse health conditions, including excessive gestational weight gain (GWG), though results have been inconsistent.
methodsParticipants (n = 539) were enrolled in the Healthy Start Study, a Colorado-based cohort (2009-2014). Eleven PFAS were measured in serum collected during pregnancy (median 27 weeks of gestation). GWG was quantified in four ways: absolute change in weight during pregnancy; GWG adjusted for the duration of pregnancy (z-score); 3rd trimester rate of weight gain; and categories of recommended GWG according to Institute of Medicine (IOM) guidelines. PFAS detectable in >60 % of samples (perfluorohexane sulfonate [PFHxS], perfluorooctane sulfonate [PFOS], perfluorooctanoate [PFOA], perfluorononanoate [PFNA], and perfluorodecanoate [PFDA]) were analyzed. We fit covariate-adjusted general linear models for continuous outcomes and multinomial logistic regression models for the categorical outcome. We evaluated effect modification by pre-pregnancy body mass index (BMI) categories.
resultsSerum concentrations of PFHxS and PFOS were positively associated with GWG, GWG z-score and greater odds of excessive weight gain. In stratified models, positive associations with GWG were stronger among women with pre-pregnancy BMI classified as overweight compared to those with BMI in the obesity or normal/underweight categories. Mixture analyses suggested that positive associations were largely due to PFOS. DISCUSSION: In a diverse population of pregnant women with PFAS serum concentrations typical of the U.S. general population, PFOS and PFHxS concentrations were associated with greater GWG. The influence of PFAS may differ by women's BMI status entering pregnancy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.